Butantan Institute Claims CoronaVac Is “Safest” Vaccine Tested in Brazil

According to the Institute's director Dimas Covas, the "high standard" demanded by the World Health Organization was achieved, and the immunizer would be the safest of those currently being tested in Brazil.

RIO DE JANEIRO, BRAZIL - During a press conference on Wednesday, December 23rd, the Butantan Institute and the government of São Paulo announced that the first results of the CoronaVac's safety and efficacy phase 3 trials had arrived. CoronaVac is a Subscribe to our Premium Membership Plan. Already Subscribed?